| human | Q5 |
| P496 | ORCID iD | 0000-0001-7952-3178 |
| P734 | family name | Page | Q13563379 |
| Page | Q13563379 | ||
| Page | Q13563379 | ||
| P106 | occupation | researcher | Q1650915 |
| Q24811133 | A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial |
| Q33229681 | A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design. |
| Q33330938 | A study of typhoid fever in five Asian countries: disease burden and implications for controls |
| Q33301096 | Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones |
| Q34941907 | Chaperones of the type III secretion pathway: jacks of all trades |
| Q38659447 | Designing HIV Testing Algorithms Based on 2015 WHO Guidelines Using Data from Six Sites in sub-Saharan Africa. |
| Q47584455 | Genomic history of the seventh pandemic of cholera in Africa. |
| Q39306485 | Global phylogeography and evolutionary history of Shigella dysenteriae type 1. |
| Q33265284 | Implementation of good clinical practice guidelines in vaccine trials in developing countries |
| Q41466218 | MxiK and MxiN interact with the Spa47 ATPase and are required for transit of the needle components MxiH and MxiI, but not of Ipa proteins, through the type III secretion apparatus of Shigella flexneri |
| Q54546861 | Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus. |
| Q55512363 | Single-dose oral ciprofloxacin prophylaxis as a response to a meningococcal meningitis epidemic in the African meningitis belt: A 3-arm, open-label, cluster-randomized trial. |
| Q77937556 | Spa15 of Shigella flexneri, a third type of chaperone in the type III secretion pathway |
| Q84317090 | The 33 carboxyl-terminal residues of Spa40 orchestrate the multi-step assembly process of the type III secretion needle complex in Shigella flexneri |
| Q34048081 | The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes |
| Q35077170 | The various and varying roles of specific chaperones in type III secretion systems. |
Search more.